Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline-Reference-Cited by-同舟云学术

Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline

Published:2014-02 Issue:2 Volume:15 Page:155-166
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Bandelow Borwin,Bauer Michael,Vieta Eduard,El-Khalili Nizar,Gustafsson Urban,Earley Willie R.,Eriksson Hans

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.3109/15622975.2013.842654

Reference67 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry

3. Escitalopram and paroxetine in the treatment of generalised anxiety disorder

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized, Placebo-Controlled Effectiveness Study of Quetiapine XR in Comorbid Depressive and Anxiety Disorders;The Journal of Clinical Psychiatry;2022-03-21

2. Quetiapine in the Anxiety Dimension of Mood Disorders;Journal of Clinical Psychopharmacology;2021-07

3. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence;Journal of Psychopharmacology;2020-10-11

4. Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disorders;Journal of Affective Disorders;2019-02

5. Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies;Neuropsychiatric Disease and Treatment;2018-12